What do I Think I Can do and What do I Really do: the Use of the Arm in Daily Life After Stroke
NCT ID: NCT04430153
Last Updated: 2021-06-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2020-10-01
2021-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Error-enhancement for Arm Rehabilitation Post Stroke
NCT05229185
Development and Validation of an Actimetric Protocol to Quantify Physical Activity and Sedentary Behaviour in Post-stroke Subjects
NCT06943014
Towards Understanding Upper Limb Rehabilitation After Stroke
NCT04721561
Feasibility of the Adapted H-GRASP Feedback Program in the Chronic Phase Post Stroke.
NCT05227521
Robot-based Therapy for Upper Limb Sensorimotor Impairments After Stroke
NCT05007002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To better understand this mismatch group, it is pivotal to investigate daily arm and hand use in patients in the chronic phase after stroke as the investigators expect patients in the mismatch group to have significantly reduced arm and hand use throughout the day. After all, stroke rehabilitation interventions intend to improve patients' performance in daily life, but the objective evaluation of this aim is a challenge. Standardized assessments performed in the rehabilitation environment or patients' home do not validly reflect daily-life upper-limb use. To achieve insight into the observed upper limb function, apart from using internationally accepted observation-based assessments such as the FMA and SIS hand function, monitoring patients after stroke will also be performed using sensor-based systems.
The investigators hypothesize the mismatch group will show a comparable daily-life UL activity profile compared to patients with both low observed and perceived function. However, when compared to patients with good observed and perceived function, the mismatch group shows significantly reduced daily-life UL activity by means of sensor-based evaluation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low match
A group with both low observed and perceived upper limb ability.
"Class 1 Medical Device" CE certified devices: ActiGraph wGT3X-BT accelerometer
Accelerometers on both patients' wrists will give insight into the daily life upper limb use.
Good match
A group with both good observed and perceived upper limb ability.
"Class 1 Medical Device" CE certified devices: ActiGraph wGT3X-BT accelerometer
Accelerometers on both patients' wrists will give insight into the daily life upper limb use.
Mismatch
A group with good observed but low perceived function.
"Class 1 Medical Device" CE certified devices: ActiGraph wGT3X-BT accelerometer
Accelerometers on both patients' wrists will give insight into the daily life upper limb use.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"Class 1 Medical Device" CE certified devices: ActiGraph wGT3X-BT accelerometer
Accelerometers on both patients' wrists will give insight into the daily life upper limb use.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Research Foundation Flanders
OTHER
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof Geert Verheyden
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Geert Verheyden
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Leuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1153320N
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
S64074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.